Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (44)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Chinnery, P. F.
Right arrow Articles by Turnbull, D. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chinnery, P. F.
Right arrow Articles by Turnbull, D. M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Brain, Vol 121, Issue 10 1889-1894, Copyright © 1998 by Oxford University Press


ARTICLES

MELAS and MERRF. The relationship between maternal mutation load and the frequency of clinically affected offspring

PF Chinnery, N Howell, RN Lightowlers and DM Turnbull
Department of Neurology, The University of Newcastle-upon-Tyne, UK.

The majority of pathogenic mitochondrial DNA (mtDNA) mutations are heteroplasmic, with both mutant and wild-type alleles present within the same individual. MtDNA is transmitted only from females to their offspring but a single female can bear offspring who harbour different levels of mutant mtDNA and have a variable phenotype. In single families, this complex genetic and phenotypic variability has confounded the identification of any relationship between the level of mutant mtDNA (mutation load) in the mother and the clinical features of her offspring. To obtain a more accurate description of the inheritance of pathogenic mtDNA mutations, we studied a large number of pedigrees that carried either the mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes (A3243G MELAS) or the myoclonic epilepsy with ragged-red fibres (A8344G MERRF) mutations. We made two principal observations. First, for both mutations, higher levels of mutant mtDNA in the mothers' blood were associated with an increased frequency of affected offspring. Secondly, at any one level of maternal mutation load there was a greater frequency of affected offspring for the A3243G MELAS mutation than for the A8344G MERRF mutation. Although these results should not be used to give absolute risks to a female contemplating pregnancy, they suggest that the outcome of pregnancy is related to the level of mutant mtDNA in the mother and that the risks of having affected offspring may differ between different mtDNA mutations.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Arch NeurolHome page
P. Kaufmann, K. Engelstad, Y. Wei, R. Kulikova, M. Oskoui, V. Battista, D. Y. Koenigsberger, J. M. Pascual, M. Sano, M. Hirano, et al.
Protean Phenotypic Features of the A3243G Mitochondrial DNA Mutation
Arch Neurol, January 1, 2009; 66(1): 85 - 91.
[Abstract] [Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
A.L. Bredenoord, G. Pennings, H.J. Smeets, and G. de Wert
Dealing with uncertainties: ethics of prenatal diagnosis and preimplantation genetic diagnosis to prevent mitochondrial disorders
Hum. Reprod. Update, January 1, 2008; 14(1): 83 - 94.
[Abstract] [Full Text] [PDF]


Home page
J. Med. Genet.Home page
C Bouchet, J Steffann, J Corcos, S Monnot, V Paquis, A Rotig, S Lebon, P Levy, G Royer, I Giurgea, et al.
Prenatal diagnosis of myopathy, encephalopathy, lactic acidosis, and stroke-like syndrome: contribution to understanding mitochondrial DNA segregation during human embryofetal development
J. Med. Genet., October 1, 2006; 43(10): 788 - 792.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
K.A.M. Majamaa-Voltti, S. Winqvist, A. M. Remes, U. Tolonen, J. Pyhtinen, S. Uimonen, M. Karppa, M. Sorri, K. Peuhkurinen, and K. Majamaa
A 3-year clinical follow-up of adult patients with 3243A>G in mitochondrial DNA
Neurology, May 23, 2006; 66(10): 1470 - 1475.
[Abstract] [Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
L.J.A.M. Jacobs, G. de Wert, J.P.M. Geraedts, I.F.M. de Coo, and H.J.M. Smeets
The transmission of OXPHOS disease and methods to prevent this
Hum. Reprod. Update, March 1, 2006; 12(2): 119 - 136.
[Abstract] [Full Text] [PDF]


Home page
J. Med. Genet.Home page
J Steffann, N Frydman, N Gigarel, P Burlet, P F Ray, R Fanchin, E Feyereisen, V Kerbrat, G Tachdjian, J-P Bonnefont, et al.
Analysis of mtDNA variant segregation during early human embryonic development: a tool for successful NARP preimplantation diagnosis
J. Med. Genet., March 1, 2006; 43(3): 244 - 247.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
P F Chinnery and E A Schon
Mitochondria
J. Neurol. Neurosurg. Psychiatry, September 1, 2003; 74(9): 1188 - 1199.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
I. Taylor, I. E. Scheffer, and S. F. Berkovic
Occipital epilepsies: identification of specific and newly recognized syndromes
Brain, April 1, 2003; 126(4): 753 - 769.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
D. Sternberg, E. Chatzoglou, P. Laforet, G. Fayet, C. Jardel, P. Blondy, M. Fardeau, S. Amselem, B. Eymard, and A. Lombes
Mitochondrial DNA transfer RNA gene sequence variations in patients with mitochondrial disorders
Brain, May 1, 2001; 124(5): 984 - 994.
[Abstract] [Full Text] [PDF]


Home page
J. Med. Genet.Home page
P. F Chinnery, N. Howell, R. M Andrews, and D. M Turnbull
Clinical mitochondrial genetics
J. Med. Genet., June 1, 1999; 36(6): 425 - 436.
[Abstract] [Full Text]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.